ACTRN12621000148875进行中（未招募）4 期
A trial of the effectiveness of vaporised nicotine products for tobacco smoking cessation amongst NSW opiate agonist treatment clients
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 入组人数
- 502
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Inclusion Criteria
- •Provide written, informed consent to participate in the study.
- •Aged 18 to 65 years
- •Be accessing opioid agonist treatment from a participating service
- •Current daily tobacco smokers on self-report
- •Want to quit or cut down their tobacco smoking
- •Be willing and able to comply with requirements of study (including having access to a phone)
排除标准
- •Currently breastfeeding or pregnant, or of childbearing potential and planning/trying to fall pregnant during the study period
- •Current, severe medical disorder assessed by study medical officer (such as but not limited to, unstable cardiovascular/peripheral vascular disease, poorly controlled hypertension)
- •Current, severe and unstable psychiatric disorder assessed by study medical officer (such as but not limited to, acute psychosis, severe anxiety and/or mood disorder, intent to harm self or others)
- •Current enrollment in a clinical trial involving any investigational drug
- •Regular use (more than one day per week) of VNP or e-Cigarette containing nicotine in the last 30 days
- •Not available for follow-up (e.g. likely imprisonment or transfer out of service to another service that is not a trial recruitment site)
研究者
相似试验
已完成
不适用
icotine nasal spray for smoking cessation in primary careTobacco dependenceMental and Behavioural DisordersMental and behavioural disorders due to use of tobaccoISRCTN03150596McNeil AB (Sweden) - formally Pharmacia and Upjohn1,200
已完成
不适用
A single-dose, randomised, crossover study to assess the nicotine pharmacokinetics of oral nicotine products in healthy adult users of smokeless pouch productsISRCTN12265853British American Tobacco (United Kingdom)53
已完成
不适用
SMOKE study: evaluation of the effectiveness of an intensive SmokeStopTherapy in an outpatient clinic setting for patients with chronic obstructive pulmonary diseaseOther chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease (COPD)RespiratoryISRCTN43240264etherlands Asthma Foundation (Netherlands)234
已完成
3 期
RELIQ Study: Reduced levels of nicotine in cigarettes to increase quittingACTRN12608000410358Heath Research Council NZ1,410
已完成
1 期
Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): Feasibility StudyACTRN12616001641482The University of Queensland30